Karadaş Ö, Özön A Ö, Özçelik F, Özge A
Department of Neurology, Ankara Mevki Military Hospital, Ankara, Turkey.
Department of Neurology, Liv Hospital, Ankara, Turkey.
Acta Neurol Scand. 2017 Apr;135(4):426-433. doi: 10.1111/ane.12692. Epub 2016 Sep 26.
This study aims to investigate the efficiency of a single and repeated greater occipital nerve (GON) block using lidocaine in the treatment of triptan-overuse headache (TOH), whose importance has increased lately.
In the study, 105 consecutive subjects diagnosed with TOH were evaluated. The subjects were randomized into three groups. In Group 1 (n=35), only triptan was abruptly withdrawn. In Group 2 (n=35), triptan was abruptly withdrawn and single GON block was performed. In Group 3 (n=35), triptan was abruptly withdrawn and three-stage GON block was performed. All patients were injected bilaterally with a total amount of 5 cc 1% lidocaine in each stage. During follow-up, the number of headache days per month, the severity of pain (VAS), the number of triptans used, and hsCRP and IL-6 levels were recorded three times; in the pretreatment period, in the second month post-treatment, and in the fourth month post-treatment. They were then compared.
There was a statistically significant difference in the post-treatment fourth month in comparison with the pretreatment period in Group 3 (P<.05). Compared to Group 1, the number of headache days, VAS, and decrease in triptan need in Group 3 was statistically significant compared to Group 2 (P<.05). Compared to pretreatment, in the fourth month post-treatment, both hsCRP and IL-6 levels were lower only in Group 3 (P<.05).
We are of the opinion that repeated GON block in addition to the discontinuation of medication has significant efficacy for TOH cases.
本研究旨在探讨使用利多卡因单次及重复枕大神经(GON)阻滞治疗曲坦类药物过度使用性头痛(TOH)的疗效,近年来该疾病的重要性日益增加。
在本研究中,对105例连续诊断为TOH的受试者进行了评估。受试者被随机分为三组。第1组(n = 35),仅突然停用曲坦类药物。第2组(n = 35),突然停用曲坦类药物并进行单次GON阻滞。第3组(n = 35),突然停用曲坦类药物并进行三阶段GON阻滞。所有患者在每个阶段双侧注射总量为5 cc的1%利多卡因。在随访期间,每月头痛天数、疼痛严重程度(视觉模拟评分法,VAS)、使用的曲坦类药物数量以及hsCRP和IL-6水平记录三次;分别在治疗前、治疗后第二个月和治疗后第四个月。然后进行比较。
第3组治疗后第四个月与治疗前相比有统计学显著差异(P <.05)。与第1组相比,第3组的头痛天数、VAS以及曲坦类药物需求的减少与第2组相比有统计学显著差异(P <.05)。与治疗前相比,治疗后第四个月,仅第3组的hsCRP和IL-6水平较低(P <.05)。
我们认为,除停药外,重复GON阻滞对TOH病例有显著疗效。